Estradiol enanthate

Estradiol enanthate (E2EN) is a shorter-acting estrogen. Estradiol enanthate is an injectable contraceptive in combination with Dihydroxyprogesterone acetophenide. Estradiol enanthate promotes withdrawal bleeding, in a pattern similar to menstruation[1].

Product Specifications

CAS Number

[4956-37-0]

Product Name Alternative

E2EN

UNSPSC

12352005

Hazard Statement

H351, H361

Target

Estrogen Receptor/ERR

Type

Reference compound

Related Pathways

Vitamin D Related/Nuclear Receptor

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Endocrinology

Assay Protocol

https://www.medchemexpress.com/estradiol-enanthate.html

Concentration

10mM

Purity

99.41

Solubility

DMSO : 125 mg/mL (ultrasonic) |Ethanol : ≥ 100 mg/mL

Smiles

C[C@@]12[C@@H](OC(CCCCCC)=O)CC[C@@]1([H])[C@]3([H])CCC4=C(C=CC(O)=C4)[C@@]3([H])CC2

Molecular Formula

C25H36O3

Molecular Weight

384.55

Precautions

H351, H361

References & Citations

[1]Elsimar M. Coutinho, et al., Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate, Contraception, Volume 73, Issue 3, 2006, Pages 249-252, ISSN 0010-7824. |[2]Gusmão-Silva, J. V., et al., (2022) . Body, metabolic and renal changes following cross-sex estrogen/progestogen therapy in a rodent model simulating its use by transwomen. Journal of endocrinological investigation, 45 (10), 1875–1885.